Zing Cheung
Papers
2
Total Citations
74
H-Index
2
About
Dr. Zing Cheung is a leading clinical researcher in the field of oncologic imaging, with a focused expertise in prostate cancer (PCa) staging using advanced molecular imaging. His work centers on the clinical utility of prostate-specific membrane antigen (PSMA) PET/CT, a cutting-edge modality that has revolutionized how clinicians detect and manage this disease. Dr. Cheung’s major contributions include demonstrating the superior accuracy of PSMA PET/CT over conventional imaging for nodal and distant staging in primary prostate cancer, a finding that has directly influenced clinical management decisions. His 2020 landmark study on this topic has garnered 55 citations, underscoring its impact on the field. Further refining this technology, his 2024 investigation into the intra- and interobserver variability of PSMA PET/CT for local staging addresses a critical gap in its application, providing essential data on its reliability for assessing disease within the prostate itself. Through these rigorous retrospective analyses, Dr. Cheung is helping to solidify PSMA PET/CT as the new standard of care, moving beyond mere detection to precise, actionable staging that guides treatment strategies for patients with high-risk disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2